The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Helena Rabie, MBChB, MMED, FCPaed
University of Stellenbosch
Study Chair - Jennifer Kiser, PharmD, PhD
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Study Chair - Patricia Flynn, MD
St. Jude Children's Research Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gaborone Crs
Gaborone, Botswana
- Molepolole Crs
Gaborone, Botswana
- Soweto Impaact Crs
Johannesburg, Gauteng, South Africa
- Wits Rhi Shandukani Research Centre Crs
Johannesburg, Gauteng, South Africa
- Umlazi Crs
Umlazi, KwaZulu-Natal, South Africa
- Famcru Crs
Tygerberg, Western Cape, South Africa
- Siriraj Hospital, Mahidol University Nichd Crs
Bangkok, Bangkoknoi, Thailand
- Chiangrai Prachanukroh Hospital Nichd Crs
Changklan, Muang, Chiang Mai, Thailand
- Chiang Mai University Hiv Treatment (cmu Hiv Treatment) Crs
Chiang Mai, Thailand
- David Geffen School of Medicine at Ucla Nichd Crs
Los Angeles, California, United States
- Univ. of Colorado Denver Nichd Crs
Aurora, Colorado, United States
- Lurie Children'S Hospital of Chicago (lch) Crs
Chicago, Illinois, United States
- Rush Univ. Cook County Hosp. Chicago Nichd Crs
Chicago, Illinois, United States
- St. Jude Children'S Research Hospital Crs
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Sept 2020
- Primary completion
- 14 Dec 2021
- Completion
- 31 May 2022
- Last update posted
- 27 Jun 2023
- Registered enrollment
- 57
- Registry id
- NCT03760458
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.